Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis (TOCRIVAR)

Clinical Trial ID NCT01752335

PubWeight™ 4.23‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01752335

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2015 2.77
2 Emerging translational approaches to target STAT3 signalling and its impact on vascular disease. Cardiovasc Res 2015 0.83
3 The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis 2015 0.80
Next 100